17-Jan-2020 | Facts and Factors
Facts and Factors Market Research has published a new report titled “Oligonucleotide Market By Product (Oligonucleotide-Based Drugs, Synthesized Oligonucleotide, Reagents, &Equipment), By Application (Research Application & Diagnostic Applications), By End-User (Hospitals, Pharmaceutical & Biological Companies, Diagnostics Laboratories, Contract Manufacturing Organization (CMOs), & Contract Research Organizations (CROs)), And By Regions - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 - 2026”. According to the report, the global oligonucleotide market was valued at approximately USD 6.4 Billion in 2020 and is expected to reach a value of around USD 14.6 Billion by 2026, at a CAGR of around 15.9% between 2021 and 2026.
Oligonucleotides are extremely-short nucleic acid polymers used in genetic testing, forensics, and research. Oligonucleotides are designed for the hybridization of specific DNA/ RNA sequences. Several solid-phase clinical syntheses manufacture small bits of nucleic acid for the purpose of DNA sequencing, polymerase chain reaction, artificial gene synthesis, and library construction. Additionally, oligonucleotides are used as probes to detect specific sequences that are complementary to oligonucleotides. When a certain sequence needs detection, a complementary oligonucleotide is synthesized in the laboratory. It is then bound to a fluorescent marker and allowed to bind to the specific RNA/DNA segment it was designed to detect. Using these molecules as probes for detection is among the most important functions of oligonucleotides.
Browse the full “Oligonucleotide Market By Product (Oligonucleotide-Based Drugs, Synthesized Oligonucleotide, Reagents, &Equipment), By Application (Research Application & Diagnostic Applications), By End-User (Hospitals, Pharmaceutical & Biological Companies, Diagnostics Laboratories, Contract Manufacturing Organization (CMOs), & Contract Research Organizations (CROs)), And By Regions - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 - 2026” Report at https://www.fnfresearch.com/oligonucleotide-market-by-offering-equipment-reagents-consumables-and-151
Rising governmental investments for R&D majorly driving the oligonucleotide market
The increasing R&D spending by the government is majorly driving the current innovations witnessed in multiple sections of the biotechnology industry. It also includes major advances made in pharmaceuticals and biological sciences and the introduction of more effective and drugs and curative and preventive treatments aimed at enhancing the quality of human life. Thus, the increasing R&D investments, both by the private sector and government, are significantly fuelling the oligonucleotide market globally. Furthermore, the rising chronic illnesses incidences due to the rapidly escalating aging population are driving the advancements in drugs that are aimed at gene therapy and oncology for preventing and treating chronic illnesses.
Synthesized oligonucleotides is projected to grow rapidly in the offering segment
Synthesized oligonucleotides is estimated to grow at a CAGR of 10.6% over the forecast time period, owing to the escalating number of manufacturers offering various customizations and rising applications of ready-to-use synthesized oligonucleotides in therapeutics. Furthermore, the presence of a robust pipeline of oligonucleotides-based therapeutics in various phases of clinical development will fuel the synthesis market in the future.
Therapeutics segment is likely to lead the application segment in the future
The therapeutics segment dominates the global market for oligonucleotide, due to the growing demand for oligonucleotides for diagnostic purposes and increasing focus on targeted gene therapies.
Asia Pacific to record highest CAGR over the estimated timeline
The Asia Pacific is the fastest-growing oligonucleotide market and will register a CAGR of 11.5% in the future, owing to the increasing regional urbanization and rising investments in the construction sector. China is a major regional player, as numerous small companies are based in the country providing reagents and consumables for oligonucleotides. Additionally, India and Japan are among other major regional contributors due to improving healthcare infrastructure.
Top Market Players
The key market participants for the global oligonucleotide market are Danaher Corporation, Thermo Fischer Scientific, Inc., Merck KGaA, LGC Limited, Maravai Life Sciences, Biogen, Inc., SareptaTherapeutics, Inc., Alnylam Pharmaceuticals, Inc., Eurofins Corporation, Ionis Pharmaceuticals, Inc., Kaneka Corporation, Agilent Technologies, Inc., and G.E Healthcare, among others.
This report segments the oligonucleotide market into:
Global Oligonucleotide Market: By Product Segment Analysis
- Oligonucleotide-Based Drugs
- Synthesized Oligonucleotide
- Reagents
- Equipment
Global Oligonucleotide Market: By Application Segment Analysis
- Research Application
- Diagnostic Applications
Global Oligonucleotide Market: By End-User Segment Analysis
- Hospitals
- Pharmaceutical & Biological Companies
- Diagnostics Laboratories
- Contact Manufacturing Organization (CMOs)
- Contract Research Organizations (CROs)
Global Oligonucleotide Market: By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
